About Event
2nd IMPACCT Real World Evidence Europe – What’s it about?
This year’s IMPACCT Real World Evidence Europe conference is the only case-study led industry forum providing actionable insights into numerous challenges such as optimizing evidence generation plans in early stages, enhancing collaboration between industry and public research to advance RWE, consolidating cross-functional collaboration to improve effectiveness of RWE studies, and exploring actionable study designs that empower patients to elevate RWE utility.
Join our 15+ expert speakers for 2 dynamic days of:
Explore strategies with Lundbeck and Pharvaris to align early evidence generation with payer and regulator expectations.
Deploying data pipelines and automation with Alexion to efficiently deliver robust RWD insights across indications.
Best practices with Novartis for sharing real-time data and insights across functions to drive informed decision-making and streamline development processes.
Addressing biases and confounding factors in ECA design through statistical techniques, matching methods, and sensitivity analyses to improve study validity with Menarini Silicon Biosystems.
Bridging the gap from clinical trials to real-world evidence in product life cycle management with Galderma.
Who Will You Meet?
Network with over 50 industry pioneers including Johnson & Johnson, Bayer, Pfizer, Takeda, AstraZeneca, Sanofi, and more. Together, let's forge a comprehensive evidence plan, break free from silos, and bridge the gap between clinical research and practice.
What Your Peers Have to Say:
“Very good opportunity for networking with companies offering services on RWD and RWE. I found interesting to listen to the experience of other companies. Very pharma oriented.”
- Edwards Lifesciences
“The variation in types of agenda items- fireside chats, presentations, mastermind sessions, speedy networking-stood out! Also, the relatively small and intimate nature of the meeting stood out."
- Lundbeck
